Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IVIEW-1201D
- Development stage
- Unknown
- Lead developer
- IVIEW Therapeutics
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
IVIEW-1201D is an investigational ophthalmic combination drug developed by IVIEW Therapeutics for the treatment of adenoviral conjunctivitis (viral pink eye). The formulation consists of low-dose povidone-iodine (PVP-I), a broad-spectrum antiseptic with potent antiviral activity, and difluprednate (DFBA), a highly potent corticosteroid. This dual-action therapy is designed to address both the underlying viral infection and the significant ocular inflammation associated with the disease. By combining the antimicrobial properties of PVP-I with the anti-inflammatory effects of difluprednate, IVIEW-1201D aims to reduce the duration and severity of adenoviral conjunctivitis, for which there are currently no FDA-approved treatments. As of late 2025, the drug has received Phase III IND clearance and is being evaluated in global Phase III clinical trials.
- Other names
- povidone-iodine + difluprednate
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on IVIEW-1201D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IVIEW-1201D.